BMJ · 1995 · 19 citations · 13 references
Life SciencesGeneticsHematologyEpidemiologyHuman GeneticsMedical GeneticsGenetic DisordersGenetic RiskInborn Errors Of MetabolismLoss Of HeterozygosityGenetic Risk PedigreesHereditary Disease Risk AssessmentInherited Disorder PedigreesMendelian RatiosRetrospective Case StudySubjectsThrombotic Risk AssessmentThrombotic Risk Stratification
OBJECTIVES: To establish the survival of individuals heterozygous for hereditary protein C deficiency, who have an increased risk of venous thrombotic events, and to compare it with the survival of the general population. DESIGN: Retrospective study in pedigrees of 23 families with hereditary protein C deficiency for period 1820 and 1993. SETTING: 23 completed family trees of 24 probands from various parts of the Netherlands with symptoms of protein C deficiency. SUBJECTS: All 736 members of the 23 families with a 50% or 100% probability of being (or having been) heterozygous for the genetic defect on the basis of DNA analysis or their place in the pedigrees, following mendelian rules. MAIN OUTCOME MEASURES: Observed mortality compared with the mortality of the general Dutch population; the standardised mortality ratio was calculated by dividing the observed mortality by the expected mortality. RESULTS: No excess mortality was found in the 206 proved heterozygous individuals and "obligatory transmitters" (those who have definitely passed on the deficiency) (standardised mortality ratio 0.95 (95% confidence interval 0.5 to 1.2)) or in the 530 family members with a 50% genetic probability of heterozygosity (1.10 (0.9 to 1.3)). CONCLUSION: Heterozygous individuals with hereditary protein C deficiency type I have normal survival compared with the general population. Prophylactic anticoagulant treatment may prevent thrombotic events in heterozygous individuals but may not be expected to improve their survival.
13
Deficiency of protein C in congenital thrombotic disease.
John H. Griffin, B. L. Evatt, T S Zimmerman et al. · Journal of Clinical Investigation · 1981 · 1.3K citations · Full text
Medicine, Genetics, Hematology +14
Efficacy of Screening Mammography
Karla Kerlikowske, Deborah Grady, Susan M. Rubin et al. · JAMA · 1995 · 1.1K citations
Homozygous Protein C Deficiency Manifested by Massive Venous Thrombosis in the Newborn
Uri Seligsohn, Anna Berger, Martha Abend et al. · New England Journal of Medicine · 1984 · 439 citations
Medicine, Genetics, Pediatrics +16
Inactivation of human coagulation factor V by activated protein C.
Koji Suzuki, Johan Stenflo, Björn Dahlbäck et al. · Journal of Biological Chemistry · 1983 · 375 citations · Full text